Lipigon Pharmaceuticals AB Sustainability Reports

Lipigon Pharmaceuticals AB develops medicines for lipid-related diseases caused by disorders in the body's handling of fats. The company's lead drug candidate focuses on lowering blood triglyceride levels.

Sector: Manufacturing

Country: Sweden

Exchange: Nasdaq Stockholm

LEI: 549300XPO40YR12SLY87

6 reports from 2020 to 2025

• Lipigon Pharmaceuticals AB 2025 Annual Report
• Lipigon Pharmaceuticals AB 2024 Annual Report
• Lipigon Pharmaceuticals AB 2023 Annual Report
• Lipigon Pharmaceuticals AB 2022 Annual Report
• Lipigon Pharmaceuticals AB 2021 Annual Report